Decision to list Medical Devices supplied by Device Technologies New Zealand Limited, Medipak Surgical NZ Limited and Draeger New Zealand Limited

Detail about this decision

In 2017 PHARMAC issued Requests for Proposals (“RFPs”) for Respiratory Care Products and Anaesthesia Products. These RFPs were for non-exclusive national agreements for listing in the Pharmaceutical Schedule.

After completing the RFP evaluation processes and consulting on the provisional Agreements reached with Device Technologies, Medipak and Draeger, PHARMAC has decided to list ranges of their medical devices in Part III of Section H of the Pharmaceutical Schedule.

The medical devices listed under these national agreements will be available on PHARMAC's website from 1 October 2018, in both a PDF document and an Excel spreadsheet.

DHB hospitals would continue to be able to choose which Anaesthesia Products and Respiratory Care Products they purchase, however would need to use these agreements should they choose to purchase Device Technologies, Medipak or Draeger medical devices listed in the Pharmaceutical Schedule, effective from 1 October 2018.  

All three companies have some products that are new to New Zealand DHBs and the Agreements would provide an increased range of devices from which clinicians could choose.

Pricing for the Anaesthesia Products and Respiratory Care Products, subject to any prior termination of the Agreements, would not be increased without prior consultation and approval by PHARMAC.

Device Technologies, Medipak and Draeger will provide training and education services that will be tailored to suit the needs of individual DHBs in formats and at times as required by DHBs.

We intend to consult on proposed agreements for Anaesthesia Products and Respiratory Care Products with additional suppliers over the next few months.